You searched for "Refraction"
ZEISS CPD Webinar: OCT Essentials for Diabetes
Speaker: Adam Heritage (ZEISS Clinical Applications Specialist) As OCT becomes increasingly important in the early detection and management of diabetic eye diseases, understanding the principles and applications of OCT is crucial. That’s why ZEISS are proud to present an interactive...In conversation with Professor Francesca Cordiero at RCOphth 2019
In this video Professor Francesca Cordiero talks to Eye News about the Duke Elder Lecture she gave on Detection of Apoptosing Retinal Cells (DARC) Development and Translation. Click the image below to see her answers to our questions.‘Let’s place focus on Scotland’s vast innovation opportunities during National Eye Health Week’
National Eye Health Week (NEHW) could provide essential inspiration for NHS Scotland staff looking to focus on fresh ophthalmic innovation, says InnoScot Health. This year's NEHW is taking place from 23 to 29 September under an inclusive theme of ‘Vision...
Long-term outcomes for hereditary retinoblastoma
Earlier diagnosis and more rigorous treatment regimens have contributed to better outcomes for patients with retinoblastoma. This study looked at 24 patients with hereditary bilateral retinoblastoma treated with systemic chemotherapy during a ten year period (2001-2011). The medical notes were...
Use of amniotic membrane in second stage Hughes tarsocunjunctival reconstruction
This is a retrospective, non-comparative interventional case series of 30 patients who underwent amniotic membrane transplantation to lower lid margin as part of Hughes lid reconstruction to prevent a hyperaemic, hypertrophic conjunctival margin with excessive discharge. Patients undergoing more than...
Delayed EPBRT efficacy in retinoblastoma
This is a retrospective medical records review of 50 patients (54 eyes) with retinoblastoma (RB), who received I-125 episcleral plaque brachytherapy (EPBRT) prior to (primary) or following chemoreduction (delayed) alone and in combination with non-irradiative focal therapy. Fifty-six plaques were...
Ocular adnexal marginal zone b-cell lymphoma
This is a multicentre retrospective study of seven eye centres of 689 patients with ocular adnexal extranodal marginal zone b-cell lymphoma (OA-EMZL). The median follow-up time was 42 months and the median age was 62 years. Fifty-five percent were women;...
Using a tumour registry to investigate optic nerve gliomas
This study is a retrospective comparative analysis. Patients with optic nerve glioma and pilocytic astrocytoma were identified through the Surveillance, Epidemiology and End Results (SEER) cancer registry covering a 42-year period using standardised codes. The following data was extracted: basic...Early detection key to improving treatment of uveitis, a leading cause globally of vision loss
New treatment guidance has been developed to help doctors tackle uveitis — one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help thousands of sufferers keep this...Specsavers joins IAPB to advocate for better eye health
The International Agency for the Prevention of Blindness (IAPB) proudly welcomes Specsavers as a pivotal new member, joining the global alliance for the eye health sector in the fight against avoidable sight loss. "For more than four decades, Specsavers has...
